Form 4 for NPCE NeuroPace Inc
Accepted 2026-06-25 16:12:02 ET · period of report 2026-06-24 · accession 0001855616-26-000019 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-25 16:12 | 2026-06-24 | NPCE | Morrell Martha | Chief MEDICAL Off | F - Tax | $16.22 | -335 | 52.0K | -0.6% | -$5,434 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-24 | F | D | 335 | $16.22 | 52,050 | D | — | — | (F1) Represents the number of shares withheld by the Issuer on June 24, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. (F1) Represents the number of shares withheld by the Issuer on June 24, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. |